Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 07/17/2026 | PUT | $42.50 | 341 | +341 | |
| 04/17/2026 | CALL | $65.00 | 531 | +300 | +129.87% |
| 04/17/2026 | PUT | $65.00 | 329 | +299 | +996.67% |
| 12/26/2025 | CALL | $57.00 | 748 | +268 | +55.83% |
| 01/02/2026 | CALL | $60.00 | 349 | +255 | +271.28% |
| 12/26/2025 | PUT | $56.00 | 236 | +171 | +263.08% |
| 04/17/2026 | PUT | $50.00 | 386 | -20 | -4.93% |
| 01/16/2026 | CALL | $72.50 | 980 | -22 | -2.20% |
| 01/16/2026 | CALL | $60.00 | 4,922 | -26 | -0.53% |
| 01/16/2026 | CALL | $75.00 | 2,770 | -29 | -1.04% |
| 01/16/2026 | CALL | $50.00 | 1,557 | -36 | -2.26% |
| 01/16/2026 | PUT | $35.00 | 635 | -40 | -5.93% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| ARK ETF Tr-ARK Innovation ETF | 7.14% | 5.61M | 322.69M |
| New Perspective Fund Inc | 4.51% | 3.55M | 204.09M |
| ARK ETF Tr-ARK Genomic Revolution ETF | 1.97% | 1.55M | 89.07M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.78% | 1.4M | 80.32M |
| Vanguard Extended Market Index Fund | 1.34% | 1.05M | 60.37M |
| Price (T.Rowe) Mid Cap Growth Fund | 1.21% | 950k | 54.61M |
| Growth Fund Of America Inc | 1.02% | 800.87k | 46.03M |
| Smallcap World Fund | 0.95% | 746.3k | 42.9M |
| iShares NASDAQ Biotechnology ETF | 0.76% | 600.21k | 34.5M |
| Fidelity Growth Company Fund | 0.75% | 589.59k | 33.89M |
12 Days of Investing: My Top 12 Stocks to Buy Before 2026
12/15 12:10 pm
The Motley Fool
Read more2 Stocks That Could Soar by 52% and 282%, According to Wall Street
12/07 10:25 am
The Motley Fool
Read moreMeet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%
11/30 05:10 am
The Motley Fool
Read moreThe Best Stocks to Buy With $1,000 Right Now
11/29 02:23 pm
The Motley Fool
Read moreMissed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
11/19 07:05 am
The Motley Fool
Read moreCRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial
11/11 10:50 am
Benzinga
Read moreHealthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
10/08 10:15 am
The Motley Fool
Read moreGene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare
10/08 10:00 am
GlobeNewswire Inc.
Read moreGot $200? 2 Healthcare Stocks to Buy and Hold Forever
10/01 05:10 am
The Motley Fool
Read moreGlobal Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
09/18 08:45 am
Benzinga
Read moreCRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
09/09 04:00 pm
GlobeNewswire Inc.
Read moreWhy This Biotech Company Could Be a Growth Stock Powerhouse
09/04 10:15 am
The Motley Fool
Read moreGene Editing Market to Surpass USD 15.46 Billion by 2032, Fueled by Breakthroughs in CRISPR Technology and Precision Medicine – SNS Insider
09/02 06:00 am
GlobeNewswire Inc.
Read moreUp 50% in 3 Months, Is This Stock Still a Buy?
08/05 07:15 am
The Motley Fool
Read moreThe 3 Things That Matter for Vertex Pharmaceuticals Now
07/28 07:15 am
The Motley Fool
Read more3 Monster Stocks in the Making to Buy Right Now
07/21 12:07 am
The Motley Fool
Read moreBreaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
07/09 08:30 am
Benzinga
Read moreCRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline
06/26 07:00 am
GlobeNewswire Inc.
Read moreThe Best Stocks to Invest $1,000 in Right Now
06/24 04:17 am
The Motley Fool
Read moreEditas Medicine Is Great. Here's Why You Shouldn't Buy It.
06/17 10:07 am
The Motley Fool
Read moreThe Best Stocks to Invest $1,000 in Right Now
06/03 04:30 am
The Motley Fool
Read more5 Monster Stocks to Hold for the Next 10 Years
05/20 04:30 am
The Motley Fool
Read morePrediction: This Beaten-Down Stock Could Double in The Next 5 Years
05/18 09:30 am
The Motley Fool
Read moreCRISPR Therapeutics Stock Near 5-Year Lows—But Gene Editing’s Future Is Just Begin
05/16 11:37 am
Investing.com
Read more2 Biotech Stocks That Are Screaming Buys in May
05/13 07:10 am
The Motley Fool
Read moreCan Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
05/12 06:18 am
The Motley Fool
Read more3 Monster Stocks to Hold for the Next 10 Years
05/10 05:12 am
The Motley Fool
Read moreWhy Recursion Pharmaceuticals Stock Plummeted 24% This Week
05/09 05:17 pm
The Motley Fool
Read moreCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
05/08 11:22 am
The Motley Fool
Read more5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years
04/20 09:15 am
The Motley Fool
Read moreCould CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
04/11 03:45 am
The Motley Fool
Read moreIs Vertex Pharmaceuticals Stock a Buy?
04/08 09:45 am
The Motley Fool
Read more4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
04/07 08:09 am
The Motley Fool
Read moreCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
04/07 07:30 am
The Motley Fool
Read moreWhy Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
04/03 09:30 am
The Motley Fool
Read moreWhy Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
03/31 03:25 pm
The Motley Fool
Read more2 Beaten-Down Stocks to Buy on the Dip
03/22 04:04 pm
The Motley Fool
Read more2 No-Brainer Biotech Stocks to Buy Right Now
03/19 06:10 pm
The Motley Fool
Read moreIf I Could Buy Only 1 Growth Stock, This Would Be It
03/10 08:30 am
The Motley Fool
Read moreGlobal Genome Editing Market to Grow Rapidly at a CAGR ~13% by 2032 | DelveInsight
03/06 02:00 pm
GlobeNewswire Inc.
Read more3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
02/28 04:15 am
The Motley Fool
Read moreBahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
02/16 08:06 am
GlobeNewswire Inc.
Read moreThe Ultimate Healthcare Stock to Buy With $500 Right Now
02/14 06:47 am
The Motley Fool
Read moreWhy CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
02/12 07:37 pm
The Motley Fool
Read moreInvesting $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
02/10 07:15 am
The Motley Fool
Read moreIs Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
02/02 06:35 am
The Motley Fool
Read moreIs Vertex Pharmaceuticals Stock a Buy in 2025?
01/26 07:30 am
The Motley Fool
Read moreMy Top 5 Stocks to Buy in Early 2025
01/23 05:15 am
The Motley Fool
Read moreMy 10 Top Stocks to Buy to Start the New Year Off Right
01/16 04:15 am
The Motley Fool
Read more